Christopher P. Mussari

Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535

Allen J. Duplantier, Mark A. Dombroski, Chakrapani Subramanyam et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 75 citations · Full text

Medicinal Chemistry, Clinical Candidate Ce-224,535, Biochemistry +9

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Ashvinikumar V. Gavai, Derek Norris, George V. Delucca et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)

Christopher P. Mussari, Dharmpal S. Dodd, Ratna Kumar Sreekantha et al. · ACS Medicinal Chemistry Letters · 2020 · 37 citations · Full text

High-Spin Metal Complexes Containing a Ferromagnetically Coupled Tris(semiquinone) Ligand

Andréa Caneschi, Andrea Dei, Christopher P. Mussari et al. · Inorganic Chemistry · 2002 · 36 citations

Inorganic Chemistry, Magnetism, Engineering +12

Electron Spin−Spin Exchange Coupling Mediated by the Porphyrin π System

David A. Shultz, Christopher P. Mussari, Krishna Kumar Ramanathan et al. · Inorganic Chemistry · 2006 · 21 citations